Matches in Nanopublications for { <http://www.nextprot.org/nanopubs#NX_P17544-1_MUTAGEN_53_53.RA-4bTH1CcfVLSuKd_Rxz7fugWIuHwOWX0Ic6ebkG5oak._1> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NX_P17544-1_MUTAGEN_53_53.RA-4bTH1CcfVLSuKd_Rxz7fugWIuHwOWX0Ic6ebkG5oak._1 type RangedSequencePosition NX_P17544-1_MUTAGEN_53_53.RA-4bTH1CcfVLSuKd_Rxz7fugWIuHwOWX0Ic6ebkG5oak.assertion.
- NX_P17544-1_MUTAGEN_53_53.RA-4bTH1CcfVLSuKd_Rxz7fugWIuHwOWX0Ic6ebkG5oak._1 type SO_0001148 NX_P17544-1_MUTAGEN_53_53.RA-4bTH1CcfVLSuKd_Rxz7fugWIuHwOWX0Ic6ebkG5oak.assertion.
- NX_P17544-1_MUTAGEN_53_53.RA-4bTH1CcfVLSuKd_Rxz7fugWIuHwOWX0Ic6ebkG5oak._1 comment "Severely reduced TAF12-induced transcriptional activity. No effect on MAPK9-mediated phosphorylation; when associated with A-51. Greatly reduces MAPK9- and adenovirus E1A-mediated transactivation; when associated with A-51 and G-112. Abolishes adenovirus 2 E1A-mediated transactivation; when associated with A-14; A-51 and G-112." NX_P17544-1_MUTAGEN_53_53.RA-4bTH1CcfVLSuKd_Rxz7fugWIuHwOWX0Ic6ebkG5oak.assertion.
- NX_P17544-1_MUTAGEN_53_53.RA-4bTH1CcfVLSuKd_Rxz7fugWIuHwOWX0Ic6ebkG5oak._1 SIO_000053 NX_P17544-1_MUTAGEN_53_53.RA-4bTH1CcfVLSuKd_Rxz7fugWIuHwOWX0Ic6ebkG5oak._2 NX_P17544-1_MUTAGEN_53_53.RA-4bTH1CcfVLSuKd_Rxz7fugWIuHwOWX0Ic6ebkG5oak.assertion.
- NX_P17544-1_MUTAGEN_53_53.RA-4bTH1CcfVLSuKd_Rxz7fugWIuHwOWX0Ic6ebkG5oak._1 SIO_000053 NX_P17544-1_MUTAGEN_53_53.RA-4bTH1CcfVLSuKd_Rxz7fugWIuHwOWX0Ic6ebkG5oak._3 NX_P17544-1_MUTAGEN_53_53.RA-4bTH1CcfVLSuKd_Rxz7fugWIuHwOWX0Ic6ebkG5oak.assertion.